Background: Elevated maternal ketone levels have been associated with adverse pregnancy outcomes(1, 2). Ketogenesis is accelerated in pregnancy, particularly in the third trimester(3). There is a paucity of information in the literature regarding the prevalence of elevated maternal ketone levels. Of the studies that do report on the prevalence, there is wide variation ranging from a prevalence of 9% to 89%(2, 4).
Aims and Methods: The aim of the study was to determine the prevalence of maternal ketonuria at the end of the first trimester, second trimester and during the third trimester. Women enrolled in the SPRING study, a study of probiotics in pregnancy, had fasting urine samples tested at 16 and 28 weeks gestation(5). The presence of ketonuria was measured via urine dipstick testing for all patients enrolled at the Royal Brisbane and Women’s Hospital. After delivery, hospital charts were reviewed to determine the rates of ketonuria in the third trimester.
Results: At 16 weeks gestation, 17/145 (12%) women had any detectable amount of ketones in their urine defined as trace amounts (0.5 mmol/L) or more. Six women had levels of ketonuria of +1 (1.5mmol/L) or more (6/145, 4%). At 28 weeks gestation, 14/123 (11%) women had any detectable amount of ketones in their urine and 7 had +1 or more (7/123, 6%). Of the women who had urine ketone levels recorded in the third trimester, 13/79 (16%) had any detectable amount of ketones in their urine and 10 had +1 or more (10/79, 13%).
Conclusion: This study showed that the prevalence of elevated maternal ketone levels in the third trimester is at least double the prevalence in the first and second trimesters. One in eight women in the third trimester had a ketone level of +1 or more. This finding potentially has important clinical implications in terms of identifying women at risk of adverse pregnancy outcomes.